INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,665 Cr | ₹1,817 Cr | ₹1,669 Cr | ₹1,541 Cr | ₹1,242 Cr |
What is the latest Revenue of INDOCO REMEDIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,665 Cr |
| Mar2024 | ₹1,817 Cr |
| Mar2023 | ₹1,669 Cr |
| Mar2022 | ₹1,541 Cr |
| Mar2021 | ₹1,242 Cr |
How is Revenue of INDOCO REMEDIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,665 Cr | -8.38 | |
| Mar2024 | ₹1,817 Cr | 8.91 | |
| Mar2023 | ₹1,669 Cr | 8.30 | |
| Mar2022 | ₹1,541 Cr | 24.10 | |
| Mar2021 | ₹1,242 Cr | - | |
Compare Revenue of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,299.2 Cr | -2.6% | 4.1% | -23.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -2.6% |
4.1% |
-23.9% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses